2ND WORLD CONGRESS ON CONTROVERSIES IN BREAST CANCER
Hilton Barcelona Hotel #Barcelona, SPAIN
WHAT TO DO AROUND HERE
Following the success of CoBRA 2015, we are pleased to announce that the 2nd World Congress on Controversies in Breast Cancer (CoBrCa) will be held in Barcelona, Spain, September 8-11, 2016.
CoBrCa will continue the tradition of directly addressing the key issues facing clinicians in their daily practice. More topics will be addressed. In addition to the key issues in medical oncology, surgery, radiation oncology and supportive care, CoBrCa will address controversial issues in radiology, pathology and reconstruction, with presentations, debates and discussions. The congress will again provide a forum to effectively debate unresolved clinical and therapeutic dilemmas.
We look forward to your participation and contribution in shaping the program and to welcoming you the vibrant and beautiful city of Barcelona.
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
Avenida Diagonal, 589-591
Abstracts should be submitted in English and contain no more than 3,600 characters, including titles, graphs and non-visible characters, such as spaces and line breaks.
Please write concisely and clearly and follow this structure:
Problem statement: Why do we care about the problem?
Methods: What did you actually do to get your results?
Results: What did you learn/invent/create?
Conclusion: What are the implications of your findings?
Please ensure that your abstract does not contain spelling, grammar or scientific mistakes, as it will be reproduced exactly as submitted. No proof reading will be done. Linguistic accuracy is the responsibility of the submitter.
An abstract cannot be accepted if the conflict of interest disclosure is not signed.
Abstracts must contain data and meet international ethical standards.
Abbreviations should be defined.
Images/graphs/tables can be uploaded according to the following criteria:
Width (in pixels): min 50 / max 750
Height (in pixels): min 50 / max 750
Size (in KB): min 20/ max 1,000
Resolution (dpi): min 72 / max 300. The standard display size for images is 96 dpi.
Format: JPG, PNG or GIF
You may improve the quality of your image for publication by increasing the number of dpi as well as the height and width of the image (in pixels).
If you wish to modify your image, you may use the programme Paint.Net (free software).
Abstract submissions that do not meet the above noted guidelines may be rejected without review.
The Scientific Committee may request additional information about abstracts and reject abstracts.
Type of Presentation
Authors should select their presentation preference. Final decision on the presentation type will be made by the Scientific Committee.
Oral presentation: The abstract is selected for oral presentation at any of the Free Communication sessions. –> Note: The number of oral presentations is limited. Abstracts with preference for oral presentation will be selected by the Scientific committee.
Poster presentation: The abstract is selected for presentation in a Poster format. Posters will be on displayed throughout the meeting.
Book only: The submitter chooses not to present the abstract in oral or poster format. The abstract will only appear in the Abstract Book.
Each submitter can present up to 2 abstracts (only 1 of which can be an oral presentation).
Creation of a user account is required for the submission of an abstract.
Accepted abstract presenters must register and pay their registration fees by the deadline date noted in the letter of acceptance. If payment is not received by the deadline date (or is received after the deadline date), the abstract(s) will be automatically withdrawn and will not appear in the Program or Abstract Book.
The Scientific Committee may request pre-registration from abstract submitters prior to abstract review.
Submitting authors will be notified as to whether their abstract has been accepted, as well as the date, time and form of their presentation.
Any change of the presenting author needs to be communicated in the form of a written statement to the Scientific Committee.
If the original presenting author is unable to present the abstract, it is that person’s responsibility to ensure that one of the co-authors takes over this role.
It is the duty of the original presenting author to advise the Congress Secretariat (CoBrCa@congressmed.com) in writing of his successor’s full name and email address.
Tel. +972 73 706 6950
Fax. +972 3 725 6266
Ilana Rabinoff-Sofer , CongressMed